Abstract
More women than men die of cardiovascular disease (CVD), and data in the literature point to the existence of gender differences pertaining to CVD. These differences may result in gender bias. Data support the existence of gender bias in referral for testing procedures and the treatment of possible CVD; in addition, research on pharmacologic agents and instruments for assessment of CVD show gender bias. The purpose of this article is to provide an overview of the extent of gender bias in the recognition, evaluation, and treatment of CVD in women. Social forces are considered, and implications for future research, patient education, diagnostic testing, methodology, and effective attitude management are delineated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
